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The Ovarian Vein Syndrome was ﬁrst reported in 1964, yet its existence as a true pathophysiological
entity remains controversial. It may present as an acute or chronic disease, typically affecting young,
multiparous women. This review discusses the literature to date on this poorly recognised cause of
ureteric obstruction and pelvic pain, including developments in the diagnosis and management of this
eminently treatable condition.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Review criteria
Using Embase and Medline, a literature search was undertaken.
English and foreign language articles on the ovarian vein syndrome
were appraised. Chronic pelvic pain, pelvic congestion syndrome
and ureteric obstructionwere key terms, which were also searched.
In 1964, Clarkpublisheda series of 129casesof right-sidedovarian
vein syndrome in which he purported that an aberrant ovarian vein
was the cause of an obstructive uropathy, occurring at the level of the
pelvic brim.1 Since then, several others have published case reports of
the ovarian vein syndrome (OVS),2–7 but the largest contemporary
series includes only eight cases.7 That the syndrome truly exists as
a distinct pathophysiological entity remains controversial. It is often
encompassedwithin a larger collection of disorders, which share the
unifying feature of chronic pelvic pain.
2. Pathophysiology
OVS may present as an acute afﬂiction during or soon after
pregnancy, or as a chronic, recurring disease. Both acute andutta).
ciates Ltd. Published by Elsevier Ltchronic variants occur most commonly in multiparous women.
Several pathophysiological mechanisms have been suggested. Clark
postulated that an aberrant ovarian vein, which might arise from
persistent embryological posterior subcardinal branches, exerts
occlusive pressure on the ipsilateral ureter.1 By crossing the ureter
at the level of the pelvic brim, where its position is relatively ﬁxed,
rather than at the usual more cephalad level of L3/L4, Clark felt the
aberrant vessel is more likely to cause ureteric compression. He also
described aberrant ovarian veins as being much larger than normal,
more likely to branch into a number of distal tributaries, and more
likely to drain into the right renal vein, all of which he felt could
explain the phenomenon of right-sided OVS (Fig. 1).
Dykhuizen described a sheath of connective tissue at the pelvic
brim, which appeared to be a retroperitoneal continuation of the
suspensory ovarian ligament, encasing both ovarian vessels and
ureter. This, he surmised, contributed to ureteric ﬁxity secondary to
periureteral ﬁbrosis.5 Radiographically he observed that, in sus-
pected right-sided OVS, the ovarian vein ﬁxed the right ureter as
they crossed, whilst the right kidney moved with respiration.
Others believe that the ureter becomes trapped within a ﬁbrovas-
cular mesh of tortuous dilated veins.3
Alternatively, pressure from the gravid uterusmay cause ovarian
vein dilatation and valvular incompetence. The dilated ovarian
veins then compress the ureter against the external iliac artery ord. All rights reserved.
Fig. 1. Normal anatomy of ovarian arteries (1), veins (2) and ureters (3) demonstrated on left. Right-hand image demonstrates an aberrant, enlarged right ovarian vein (4),
compressing the right ureter (5) between itself and the external iliac vessels (6).
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pressures are needed for the ovarian veins to feasibly occlude
a thick-walled muscular ureter. Such pressures are not achieved,
even during pregnancy.8 Dure-Smith argued that whilst the pres-
sure of the gravid uterus itself may sufﬁce to occlude the ureters, it
seems unlikely that ovarian vein pressure could achieve this.
Quoting studies demonstrating a 60-fold increase in blood ﬂow
through the ovarian veins during pregnancy, and a 3-fold increase
in venous diameter, but a comparatively small rise in pressure in
these capacitance vessels,9 he argued that ovarian veins could only
reach pressures high enough to occlude the ureters during labour,
or with transient activities such as the valsalva manoeuvre. He
contested that post-partum, the ovarian veins collapse, so post-
pregnancy ureteric dilatation caused by the ovarian veins seems
implausible. He also felt that the presence of a connective tissue
sheath encasing vessels and ureter was dubious, and not described
by anyone other than Dykhuizen, although subsequently, this
observation has been corroborated.10 Canine experiments repro-
ducing ovarian vein dilatation by ligating other main veins have
failed to reproduce ureteric obstruction.11 In Dykhuizen’s series,
extirpated ovarian veins demonstrated medial wall thickening,
although others have found the vessels to be histologically normal.3
Hormonal changes associated with pregnancy may also explain
OVS. Altered levels of circulating oestrogen and progesterone could
affect the muscular ureteric wall, causing a decrease in tone that
facilitates its compression.12,13 In Dykhuizen’s series, oral proges-
togen appeared to exacerbate symptoms, presumed to be due to
increased ovarian vein blood ﬂow.5 Oestrogen may account for the
development of pelvic varicosities in the pelvic congestion
syndrome, via nitric-oxide mediated vascular smooth muscle
relaxation.14 Similarly, oestrogen/progesterone imbalances during
pregnancy are a putative biological mechanism leading to ovarian
vein dilatation and OVS. The hormonal hypothesis is strengthened
by the trend for symptoms of OVS to be cyclical, and theobservation that it primarily affects pre and peri-menopausal
women.1,6,7 However, that oophorectomy does not seem to be
a successful treatment for OVS weakens the hormonal hypothesis.1
More rarely, an ovarian varicocele may develop as a result of
back-pressure from the inferior vena cava or left renal vein. An
example of this is the ‘nutcracker syndrome’, inwhich the left renal
vein is compressed between the aorta and the superior mesenteric
artery.15
Historically, the right ureter is involved in OVS more commonly
than the left.1,4 This might be explained by its proximity to the iliac
vessels, and the course of the right ovarian vein. The right ovarian
vein usually forms a direct anastamosis with the inferior vena
cava.8 Aberrant veins draining into the right renal vein might be
responsible for the development of OVS.1,7 However, post-mortem
examinations show that the left ovarian vein, which usually drains
into the left renal vein, is twice as likely as the right to be valve-
less,16 and the left vein usually expands to a greater degree than the
right both during and after pregnancy.17 These observations suggest
that the left ovarian vein is more susceptible to becoming varicose.
Incidental ovarian varices are present in 10–47% of females.18,193. Clinical features
OVS is uncommon in nulliparous women.1,7 Symptoms are
variable and non-speciﬁc, including abdominal pain, particularly in
the iliac fossae, ﬂanks and hypochondrium. The pain tends to be
positional, and is worse lying down on the affected side. It is often
cyclical, peaking shortly before menstruation.1,7 Urinary symptoms
from ureteric obstruction include recurrent urinary tract infections,
hydronephrosis, pyelonephritis, renal colic and frank haematuria.
Whilst antibiotic therapy effectively treats infection, OVS pain
is refractory, requiring more deﬁnitive treatment.5 Despite
ureteric obstruction, there are few data regarding effects on renal
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abnormality.20,21
Given the non-speciﬁc features of OVS, the differential diagnosis
is broad. Gynaecological conditions such as endometriosis, pelvic
inﬂammatory disease and salpingitis must be considered. Ovarian
vein thrombophlebitis, a condition which typically presents in the
ﬁrst few days post-partum with iliac fossa pain, fevers, and often
a pelvic or abdominal mass should be excluded if such features are
present.
3.1. Ovarian vein syndrome vs. pelvic congestion syndrome
OVS should be distinguished from Pelvic Congestion Syndrome
(PCS). Whilst sharing a similar pathology (dilated ovarian veins),
affecting a similar demographic (women of child-bearing age), and
responding to similar surgical treatment (venous embolization/
ligation), the clinical manifestation is different. OVS is attributed to
dilated ovarian veins only, whilst PCS is thought to be a manifes-
tation of dilatation of the entire anastomotic network of pelvic
veins (ovarian, uterine, iliac), often with distal extension to involve
lower limb veins22 .
PCS is characterised by cyclical pelvic pain, often preceding the
onset of menstruation. It typically, but not exclusively, begins
during pregnancy in multiparous women, when the gravid uterus
causes pressure on, with subsequent dilatation of, the ovarian
veins.23 A dull ache and a sensation of perineal heaviness persist
beyond pregnancy, and vascular congestion spreads distal to the
ovarian veins giving rise to vulval and lower limb varicosities, with
congestion of the pelvic organs. Pain is often postural, being worse
on standing and eased on lying down, and patients complain of
dyspareunia and post-coital pain.24 Urinary symptoms are infre-
quent, with urinary frequency and urgency being the most preva-
lent features. On clinical examination, there is commonly point
tenderness over the region of the ovary and cervical excitation. By
contrast, OVS is typiﬁed by a constellation of urinary symptoms.
Extrinsic compression of the ureters such as tumour compres-
sion or retroperitoneal ﬁbrosis, renal colic, and infections e.g.
tuberculosis, are all possible differentials, as are general surgical
emergencies such as appendicitis. Neurological and musculoskel-
etal disorders should also be considered. Consequently, many feel
that OVS is ultimately a diagnosis of exclusion.20
4. Diagnostic testing
First line investigations include both abdominal and trans-
vaginal ultrasonography to assess the genitourinary tract, and
principally to exclude mass lesions, which may be accountable
for the presenting symptoms. An ovarian vein diameter  6 mm
on ultrasound scan indicates an ovarian varicosity,25 while
duplex scanning may demonstrate reversed or reduced ﬂow.
These ﬁndings form part of the imaging criteria for a diagnosis of
PCS, but they may equally be applied to OVS. However, Park et al.
found that the right ovarian vein was not identiﬁed with duplex
scanning in 90% of subjects.26 Intravenous urography typically
demonstrates a hydroureter, with a clearly demarcated trans-
verse defect at the L3/4 level. The renal pelvis and calyces may be
spared,4 and the middle third of the ureter may be laterally
displaced, with medial displacement of a normal calibre pelvic
ureter.5 Marked improvement in hydroureter may be seen on
post-operative intravenous urogram, in keeping with a clinical
improvement in many case reports.3,4,10
Secondary investigations include retrograde pyelography, which
demonstrates a similar ureteric appearance as seen on intravenous
urography, with an often normal pelvic ureteric segment,
and delayed drainage.4 Percutaneous ovarian venography hashistorically been regarded as the gold standard investigation in
OVS, clearly identifying varicose veins and demonstrating retro-
grade blood ﬂow.It is especially useful if considering ovarian vein
embolization. Ovarian veins>10 mm in diameter are accepted as
being varicose on venography.27
Ovarian varicosities may also be apparent on contrast-enhanced
computed tomography (CT) or magnetic resonance imaging (MRI).
MRI is preferable as it avoids the large radiation dose associated
with CT, which should be avoided where possible in young women.
Additionally, contrast-enhancedMRI permits images to be obtained
in arterial and venous phases, though this is being superseded by
magnetic resonance venography,28 which may actually identify the
cause of ovarian varicoceles. For PCS, an ovarian vein
diameter  8 mm on CT or MRI is considered diagnostic.29 This
criterion might equally be applied to identify ovarian varicosities in
OVS. Up to 47% of women may have ovarian vein dilation observed
incidentally on scans performed for other reasons.19 Use of MRI for
OVS follow-up post-embolization with coils is limited by artefact.
Laparoscopy may also have a diagnostic and therapeutic role,
particularly in excluding other aetiologies, but is not typically a ﬁrst
line investigation. Pelvic pain is the commonest indication for
diagnostic laparoscopy, but no diagnosis is made in the majority of
cases.30 Studies to compare the sensitivity and speciﬁcities of these
various investigations in either the ovarian vein syndrome, or the
more well known pelvic congestion syndrome, have not been
published. Whilst ultrasonography is clearly user-dependent, CT
and MRI may both underestimate the presence of varicose veins as
they collapse whilst the patient is supine during CT and MR
imaging.5. Treatment
5.1. Medical therapy
Medical therapies with medroxyprogesterone acetate (MPA) as
a method of causing venous contraction, and with goserelin acetate
(gonadotrophin releasing hormone analogue), have been used in
the treatment of chronic pelvic pain although long-term relief
seems limited.31 In a randomised trial comparingMPA directly with
goserelin acetate in the treatment of women with PCS, 12 months
after the completion of treatment, goserelin acetate was found
to be more effective than MPA, both subjectively, reducing
pelvic symptoms and anxiety, and radiologically, reducing
pelvic congestion on venography.32 Recently, the sub-dermal eto-
norgestrol implant (Implanon) has shown promise in treating
PCS-related pelvic pain, with follow-up at 12 months showing
signiﬁcant reduction in pain scores and improved venographic
appearances compared with no treatment.335.2. Radiological therapy
Ovarian vein embolization has been used for many years as
a treatment for OVS resistant to medical therapy. Coil embolization,
ﬁrst described in 1993,34 and now percutaneous chemical scle-
rotherapy with Gelfoam35 or sodium tetradecylsulphate35,36 can be
offered on an out-patient basis as less invasive options than
surgery. Short-term success from embolization therapy is esti-
mated at 80–98%.37–39 Longer-term efﬁcacy, as observed in PCS,
also appears promising.40 Technical success rates from embolo-
therapy for the treatment of varices in PCS have been measured at
98–100%, and follow-up at 12 months has shown a mean reduction
in pain scores of 65%.41 Side- effects of embolization include
thrombophlebitis, recurrent disease, and embolic material
occluding non-targeted veins.
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The ﬁrst case report of transperitoneal laparoscopic treatment
for OVS was in 1996, by Elashry et al.42 Laparoscopy has subse-
quently been undertaken by many to achieve ovarian vein liga-
tion,7,20,43–45 with promising short-term results, offering various
degrees of resolution of symptoms and improvement in radiolog-
ical appearances of the dilated ureteropelvicalyceal system. Prior to
this, open ligation of the ovarian vein with ureterolysis was the
preferred method of treatment.3,42,46 Clark reported good results
with open surgery in his early series of 130 cases.1 Ligation of the
ovarian veins is permitted by a vast collateral network formed with
the uterine veins, and is not believed to affect future fertility or
pregnancies.1,7 Laparoscopic treatment has progressed more
recently to involve use of the retroperitoneoscopic approach10 and
sophisticated robotic devices,47 and whilst it is preferable to oper-
ate post-partum, if symptoms are severe enough, laparoscopy can
be undertaken during pregnancy.
6. Conclusion
The debate around the ovarian vein syndrome continues since
Dure-Smith questioned the plausibility of its pathophysiological
development 30 years ago. However, it is deemed by many to be
a very real and easily curable cause of chronic pelvic pain in young
women, who might otherwise suffer considerable physical and
psychological morbidity when no other explanation for their pain
can be found. It should be considered as a last resort in all young
female patients presenting with chronic pain.
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